A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
Clinical trial NCT06435429 · RECRUITING
Trial details
- NCT number
- NCT06435429
- Sponsor
- Jazz Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-13
- Primary completion
- 2028-04-28
- Enrollment
- 550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.